1. Wei SC. Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries. Intest Res. 2016; 14:218–223.
Article
2. Kim ES, Chen M, Lee J, Lee CK, Kim YS. Diagnosis of inflammatory bowel disease in Asia: the results of a multinational webbased survey in the 2
nd Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016; 14:224–230.
Article
3. Nakase H, Keum B, Ye BD, Park SJ, Koo HS, Eun CS. Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2
nd Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016; 14:231–239.
Article
4. Song HK, Lee KM, Jung SA, Hong SN, Han DS, Yang SK. IBD study group of Korean Association for the Study of Intestinal Diseases (KASID). Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2
nd Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res. 2016; 14:240–247.
Article
5. Burisch J, Jess T, Martinato M, Lakatos PL. ECCO -EpiCom. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013; 7:322–337. PMID:
23395397.
Article
6. Ye BD, Jang BI, Jeen YT, et al. Diagnostic guideline of Crohn's disease. Korean J Gastroenterol. 2009; 53:161–176. PMID:
19835218.
7. Choi CH, Jung SA, Lee BI, et al. Diagnostic guideline of ulcerative colitis. Korean J Gastroenterol. 2009; 53:145–160. PMID:
19835217.
8. Ueno F, Matsui T, Matsumoto T, et al. Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013; 48:31–72. PMID:
23090001.
Article
9. Kim SH, Kim JW, Jeong JB, Lee KL, Kim BG, Choi YH. Differential diagnosis of Crohn's disease and intestinal tuberculosis in patients with spontaneous small-bowel perforation. Dig Surg. 2014; 31:151–156. PMID:
24970687.
Article
10. Bernstein CN. Treatment of IBD: where we are and where we are going. Am J Gastroenterol. 2015; 110:114–126. PMID:
25488896.
Article
11. Dubinsky MC. Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease. World J Gastroenterol. 2010; 16:2604–2608. PMID:
20518081.
Article
12. Guerra I, Bermejo F. Management of inflammatory bowel disease in poor responders to infliximab. Clin Exp Gastroenterol. 2014; 7:359–367. PMID:
25258548.
13. Melmed GY, Siegel CA, Spiegel BM, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013; 19:662–668. PMID:
23388547.
14. Sam JJ, Bernstein CN, Razik R, Thanabalan R, Nguyen GC. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Dig Dis Sci. 2013; 58:46–52. PMID:
23053902.
Article